BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1835095)

  • 1. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitogenesis and programmed cell death as determinants of carcinogenicity of nongenotoxic compounds.
    Schulte-Hermann R; Bursch W; Parzefall W
    Prog Clin Biol Res; 1991; 369():237-44. PubMed ID: 1946522
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth kinetics of diethylnitrosamine-induced, enzyme-deficient "preneoplastic" liver cell populations in vivo and in vitro.
    Rabes HM; Scholze P; Jantsch B
    Cancer Res; 1972 Nov; 32(11):2577-86. PubMed ID: 4263646
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative study on foci of altered liver cells induced in the rat by a single dose of diethylnitrosamine and partial hepatectomy.
    Scherer E; Hoffmann M; Emmelot P; Friedrich-Freksa M
    J Natl Cancer Inst; 1972 Jul; 49(1):93-106. PubMed ID: 4114003
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemically induced cell proliferation in liver carcinogenesis.
    Popp JA; Marsman DS
    Prog Clin Biol Res; 1991; 369():389-95. PubMed ID: 1946534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response.
    Bannasch P; Zerban H
    IARC Sci Publ; 1992; (116):389-427. PubMed ID: 1428091
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of FK 506 on experimental liver carcinogenesis.
    Shinozuka H; Warty VS; Masuhara M; Murase N; Iwatsuki S
    Transplant Proc; 1991 Dec; 23(6):3197-9. PubMed ID: 1721407
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of a 65-kDa tumor-associated protein and persistence of altered hepatic foci.
    Hanausek M; Sherman U; Adams AK
    Prog Clin Biol Res; 1991; 369():91-103. PubMed ID: 1946546
    [No Abstract]   [Full Text] [Related]  

  • 11. Short term induction of preneoplastic nodules in the rat liver. I. The role of 2-AAF as selecting agent.
    van der Heijden CA; Dormans JA; van Nesselrooij JH
    Eur J Cancer (1965); 1980 Nov; 16(11):1389-98. PubMed ID: 7227415
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of tumor promoters on proliferation of putative preneoplastic cells in rat liver.
    Schulte-Hermann R; Schuppler J; Ohde G; Timmermann-Trosiener I
    Carcinog Compr Surv; 1982; 7():99-105. PubMed ID: 6175416
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferation kinetics and development of pepsinogen-altered pyloric gland cells in the glandular stomach of rats treated with chemicals.
    Tatematsu M; Shirai T; Ogawa K; Asamoto M; Ito N
    Prog Clin Biol Res; 1991; 369():445-55. PubMed ID: 1946539
    [No Abstract]   [Full Text] [Related]  

  • 14. Stochastic description of initiation and promotion in experimental carcinogenesis.
    Luebeck EG; Moolgavkar SH
    Ann Ist Super Sanita; 1991; 27(4):575-80. PubMed ID: 1840318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foci of altered liver cells induced by a single dose of diethylnitrosamine and partial hepatectomy: their contribution to hepatocarcinogenesis in the rat.
    Scherer E; Emmelot P
    Eur J Cancer (1965); 1975 Mar; 11(3):145-54. PubMed ID: 124252
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transplacental teratogenic, carcinogenic and mutagenic effect of diethylnitrosamine (DENA) following oral administration in rats].
    Sydow G
    Arch Geschwulstforsch; 1970; 36(4):331-4. PubMed ID: 5513530
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent changes induced by subcarcinogenic doses of 3'-methyl-4-(dimethylamino)azobenzene in rat liver.
    Ogawa K; Kaneko A; Minase T; OnoƩ T
    Gan; 1974 Apr; 65(2):109-17. PubMed ID: 4366072
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sensitivity of hepatocytes to the effect of factors stimulating and suppressing cell proliferation in hepatocarcinogenesis].
    Osipova LA
    Eksp Onkol; 1984; 6(2):23-6. PubMed ID: 6510330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.
    Thomas RS; Conolly RB; Gustafson DL; Long ME; Benjamin SA; Yang RS
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):128-37. PubMed ID: 10896854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.